|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,790 KRW | +3.14% |
|
+7.10% | -8.36% |
CJ Bioscience, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 158.76 million compared to KRW 51.05 million a year ago. Net loss was KRW 7,277.47 million compared to KRW 6,159.91 million a year ago.
Basic loss per share from continuing operations was KRW 1,238 compared to KRW 1,049 a year ago. Basic loss per share was KRW 1,238 compared to KRW 1,049 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.36% | 94.99M | |
| +0.41% | 42.86B | |
| +11.75% | 42.74B | |
| +44.30% | 41.36B | |
| -6.20% | 27.68B | |
| +5.53% | 25.15B | |
| -24.23% | 18.63B | |
| +27.56% | 12.37B | |
| -3.04% | 11.92B | |
| +7.06% | 11.21B |
CJ BIOSCIENCE, INC. 
